Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases

par V V Fomin, A A Pulin, N A Mukhin
Publié 2013-06-01

Clinical significance of serum and urinary biomarkers for water-salt metabolism in patients with proteinuric forms of chronic glomerulonephritis

par A A Pulin, M Iu Brovko, T Iu Kustova, L V Kozlovskaia, V V Fomin, N A Mukhin
Publié 2014-06-01

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry

par M. M. Lukyanov, N. P. Kutishenko, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publié 2022-04-01

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from...

par M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, А. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publié 2022-01-01

Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessme...

par O. M. Drapkina, O. E. Karpov, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, V. G. Akimkin, E. Yu. Andrenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, E. V. Kudryashov, V. G. Klyashtorny, A. A. Smirnov, V. S. Fomina
Publié 2020-12-01